1,395 companies
ACHL
Achilles Therapeutics Plc
achilles therapeutics’ mission is to develop next-generation, patient-specific therapies that harness the immune system to destroy cancer cells.
United Kingdom
NASDAQ
Actis Arroyo PIV LP
United Kingdom
Actis Asia Climate Transition LP
United Kingdom
Actis Asia Real Estate 2 A LP
United Kingdom
Actis Asia Real Estate 2 Centro Co-Investment LP
United Kingdom
Actis Asia Real Estate 2 LP
United Kingdom
Actis Asia Real Estate Carrock Co-Investment LP
United Kingdom
Actis Energy 5 A LP
United Kingdom
Actis Energy 5 Amber Co-Investment LP
United Kingdom
Actis Energy 5 Discretionary Co-Investment LP
United Kingdom
Actis Energy 5 LP
United Kingdom
Actis GP LLP
United Kingdom
Actis Long Life Infrastructure 2 A LP
United Kingdom
Actis Long Life Infrastructure 2 A SCSp
United Kingdom
Actis Long Life Infrastructure 2 LP
United Kingdom
Actis Long Life Infrastructure 2 SCSp
United Kingdom
ADAP
Adaptimmune Therapeutics Plc
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer.
United Kingdom
NASDAQ
Adelphi Capital LLP
United Kingdom
Adelphi Europe Fund
United Kingdom
Adelphi Europe Long Only Fund LTD.
United Kingdom